Aspiro Pharma Limited Ketorolac Export Data — India (DGFT 2022–2026)

Name: Aspiro Pharma Limited Ketorolac Export Records India — #7 Exporter, 26 Shipments, $1.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ketorolac

India Pharmaceutical Trade Intelligence

$115.9M351 Suppliers124 CountriesHS 30049067

ExportsIndia → UNITED STATES63.1%India → RUSSIA23.4%

ImportsUNITED STATES → India$722.1K UNITED KINGDOM → India$13.4K

#1 Supplier: GLAND PHARMA #1 Buyer: EVERSANA LIFE

Aspiro Pharma Limited — Ketorolac Exporter #7 | $1.2M Trade Value | TransData Nexus | TransData Nexus

Aspiro Pharma Limited — Ketorolac Exporter Profile

Indian Pharmaceutical Exporter · #7 for Ketorolac · $1.2M export value · DGFT Verified

Aspiro Pharma Limited is the #7 Indian exporter of Ketorolac with $1.2M in export value and 26 verified shipments. Aspiro Pharma Limited holds a 1.0% market share in Ketorolac exports across 7 countries. The company exports 3 pharmaceutical products worth $8.0M across 3 therapeutic categories.

Aspiro Pharma Limited — Ketorolac Export Profile: Buyers & Destinations

Aspiro Pharma Limited Ketorolac export treemap — buyers and destination countries | TransData Nexus

Where Does Aspiro Pharma Limited Export Ketorolac?

Country	Value	Shipments	Share
UNITED STATES	$651.3K	14	85.6%
POLAND	$39.4K	2	5.2%
THAILAND	$37.3K	6	4.9%
SOUTH AFRICA	$15.1K	1	2.0%
MEXICO	$10.5K	1

Who Are the Top Buyers of Ketorolac from Aspiro Pharma Limited?

Buyer	Country	Value	Orders
CAMBER PHARMACEUTICALS	UNITED STATES	$294.1K	6
TO THE ORDER	UNITED STATES	$181.5K	4
TO THE ORDER OF	UNITED STATES	$177.1K	5
TO THE ORDER OF.,	POLAND	$22.3K	1
S PHARMA LTD	POLAND	$17.0K	1
CAMBER PHARMACEUTICAL CO., LTD	THAILAND	$16.0K	3
HETERO DRUGS SOUTH AFRICA (PTY)LTD.	SOUTH AFRICA	$15.1K	1
M S TO THE ORDER OFCAMBER PHARMACEUTICAL CO	THAILAND	$14.4K	2
ABSOLUTE BROKERAGE CUSTOMS SC	MEXICO	$10.5K	1
CAMBER PHARMACEUTICAL CO LTD	THAILAND	$6.9K	1

Aspiro Pharma Limited supplies Ketorolac to 11 buyers globally. The largest buyer is CAMBER PHARMACEUTICALS (UNITED STATES), followed by TO THE ORDER (UNITED STATES) and TO THE ORDER OF (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ketorolac Formulations Does Aspiro Pharma Limited Export?

Product Description / Formulation	Value	Shipments
KETOROLAC TROMETHAMINE INJ	$501.3K	11
KETOROLAC TROMETHAMINE INJECTION 25S	$150.0K	3
KETORZ KETOROLAC TROMETHAMINE 30MG VIAL	$22.3K	1
TORO KETOROLAC TROMETHAMINE 30MG INJ	$17.0K	1
KETAZ 30 KETOROLAC TROMETHAMINE 30MG VIALNOS	$16.0K	3
OFLAECT KETOROLAC TROMETHAMINE INJ	$15.1K	1
KETAZ 30KETOROLAC TROMETHAMINE 30MG VIAL	$14.4K	2
MEVIDIR KETOROLAC TROMETHAMINE 30MG VIAL	$10.5K	1
KETAZ KETOROLAC TROMETHAMINE 30MG VIAL	$6.9K	1
KETOROLAC TROMETHAMINE 30MG INJ 2999X10S=29990 INJ	$6.4K	1

Aspiro Pharma Limited exports 11 distinct Ketorolac formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KETOROLAC TROMETHAMINE INJ with 11 shipments worth $501.3K.

How Does Aspiro Pharma Limited Compare to Nearest Ketorolac Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	ALEMBIC PHARMACEUTICALS LIMITED	$3.5M	70	1	$50.0K
6	MICRO LABS LIMITED	$3.0M	60	10	$50.0K
7	ASPIRO PHARMA LIMITED ★	$1.2M	26	7	$45.6K
8	WEXFORD LABORATORIES PRIVATE LIMITED	$1.1M	50	6	$22.9K
9	TORRENT PHARMACEUTICALS LTD	$857.1K	61	1	$14.1K

Aspiro Pharma Limited ranks #7 among 351 Indian Ketorolac exporters. Average shipment value of $45.6K compared to the market average of $141.1K. The closest competitors by value are ALEMBIC PHARMACEUTICALS LIMITED and MICRO LABS LIMITED.

Which Indian Ports Ship Ketorolac Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	337	11.4%
SAHAR AIR	229	7.7%
NHAVA SHEVA SEA (INNSA1)	227	7.7%
HYDERABAD ICD (INSNF6)	127	4.3%
HYDERABAD AIR	93	3.1%
DELHI AIR	92	3.1%
DELHI AIR CARGO ACC (INDEL4)	75	2.5%
HYDERABAD ICD	74	2.5%

Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Ketorolac Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Aspiro Pharma. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical challenges can impact the timely delivery of pharmaceuticals, which is critical for maintaining supply chain integrity and meeting contractual obligations. (pharmaceuticalcommerce.com)

Conversely, the US-China trade tensions have opened avenues for Indian exporters to fill the gap left by Chinese suppliers. Aspiro Pharma can leverage this opportunity by strengthening its presence in the US market, especially given India's existing supply of 40% of the US's generic drug needs. (ibef.org) However, potential US tariffs on pharmaceutical imports necessitate a cautious approach, as they could affect pricing strategies and profit margins. (business-standard.com)

The recent India-European Union Free Trade Agreement (FTA) signed in January 2026 is another significant development. The FTA aims to eliminate tariffs on pharmaceuticals, potentially enhancing market access for Indian exporters. Aspiro Pharma should monitor the implementation of this agreement to capitalize on reduced trade barriers and expand its footprint in the European market. (en.wikipedia.org)

Aspiro Pharma Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is a cornerstone for success in pharmaceutical exports. India has made significant strides in this area, surpassing the US in the number of FDA-registered generic manufacturing sites, with 752 FDA-approved facilities as of 2024. (business-standard.com) For Aspiro Pharma, maintaining stringent quality control measures and adhering to Good Manufacturing Practices (GMP) are essential to ensure continued access to regulated markets.

The European Union's Falsified Medicines Directive (FMD) imposes additional requirements for traceability and verification of pharmaceutical products. Aspiro Pharma must ensure compliance with these regulations to prevent counterfeit medicines from entering the supply chain and to maintain trust with European partners.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ketorolac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Aspiro Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 26 individual customs records matching Aspiro Pharma Limited exporting Ketorolac, covering 11 formulations to 7 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 124+ countries, 638+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ketorolac

Ketorolac

Aspiro Pharma Limited — Ketorolac Exporter Profile

Aspiro Pharma Limited — Ketorolac Export Profile: Buyers & Destinations

Where Does Aspiro Pharma Limited Export Ketorolac?

Who Are the Top Buyers of Ketorolac from Aspiro Pharma Limited?

What Is India's Total Ketorolac Export Value and How Much Does Aspiro Pharma Limited Contribute?

What Is the Average Shipment Value for Aspiro Pharma Limited's Ketorolac Exports?

How Does Aspiro Pharma Limited Compare to Other Indian Ketorolac Exporters?

What Ketorolac Formulations Does Aspiro Pharma Limited Export?

Regulatory Requirements: Exporting Ketorolac to Key Markets

United States — FDA

How Does Aspiro Pharma Limited Compare to Nearest Ketorolac Exporters?

Which Indian Ports Ship Ketorolac Exports?

Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Ketorolac Exports

Aspiro Pharma Limited — Regulatory Compliance & Quality Standards

About Aspiro Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ketorolac Export Data from Aspiro Pharma Limited

Ketorolac Stats

Company Overview

Top Products by Aspiro Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source